NCT06589804 2026-04-17Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous TreatmentNational Cancer Institute (NCI)Phase 3 Recruiting158 enrolled
NCT07222566 2026-04-08Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerPfizerPhase 3 Recruiting1,410 enrolled
NCT05721755 2026-03-05Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and NeckEastern Cooperative Oncology GroupPhase 3 Active not recruiting290 enrolled
NCT03976323 2026-02-25Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)Merck Sharp & Dohme LLCPhase 3 Completed1,003 enrolled 23 charts